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Abstract 
Mobile medical apps (MMAs) are a fast‐growing category of software typically installed on personal 
smartphones and wearable devices. A subset of MMAs are aimed at helping consumers identify mental 
states and/or mental illnesses. Although this is a fledgling domain, there are already enough extant mental 
health MMAs both to suggest a typology and to detail some of the regulatory issues they pose. As to the 
former, the current generation of apps includes those that facilitate self‐assessment or self‐help, connect 
patients with online support groups, connect patients with therapists, or predict mental health issues. 
Regulatory concerns with these apps include their quality, safety, and data protection. Unfortunately, the 
regulatory frameworks that apply have failed to provide coherent risk‐assessment models. As a result, 
prudent providers will need to progress with caution when it comes to recommending apps to patients or 
relying on app‐generated data to guide treatment. 
1 INTRODUCTION 
While information and data technologies have successfully disrupted various “bricks‐and‐mortar” (legacy 
or traditional) industries, such as retail and music or video distribution, they have been less successful in 
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disrupting healthcare delivery (Terry, 2013). Notwithstanding this, mental healthcare remains a prime 
candidate for disruptive technologies that can provide access to care of some kind to a population that has 
continually challenged the healthcare system. In large part this may be triggered by the relative failure of 
legacy healthcare and its financing models to deal with increasing mental health populations that are not 
infrequently marginalized and distant from centers of care. In the United States alone, more than 43.4 
million adults (about 18%) suffer from mental illness (National Institute of Mental Health, 2015) In 
addition to formally diagnosed mental illness, some authors express concern about behaviors that may 
signal mental health issues, such as increases in self‐harming behavior and suicidal ideation among young 
people (Mercado, Holland, Leemis, Stone, & Wang, 2017).  
This article places the current generation of mental health apps in their technological context and suggests 
a basic typology. After an introduction to general categories of apps, the article focuses on some of the 
quality, safety, and data protection issues raised by these apps and explores the fragmented approaches 
taken by regulatory agencies. Of course, utilizing mental health apps to diagnose or manage mental health 
conditions is not without the potential for adverse events given that excessive media screen time has been 
linked to depression and suicide‐related outcomes, particularly when combined with decreases in 
socialization and other terrestrial activities known to be associated with wellness (Twenge, Joiner, 
Rogers, & Martin, 2017). Nonetheless, for the purposes of this article we shall assume that apps may have 
a role in facilitating access to services without raising risk. As noted by David Dobbs in his interview 
with Dr. Tom Insel, the former director of the National Institute of Mental Health, “At any given moment, 
roughly one in seven of the world's 7.5 billion people is struggling with mental illness. ‘We're not going 
to reach all those people by hiring more psychiatrists,’ says Insel. But we might reach them with 
smartphones” (Dobbs, 2017).  
2 PROVIDER‐FACING TECHNOLOGIES AND PATIENT‐FACING MOBILE MEDICAL APPS 
Emerging data‐driven healthcare technologies such as MMAs can be classified as either provider‐facing 
or consumer/patient‐facing (Terry, 2016, 2017). Provider‐facing technologies remain under the control of 
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legacy healthcare providers while consumer‐facing technologies tend to be marketed directly to 
consumers or patients by developers or non‐healthcare service providers to meet self‐identified needs 
and/or promote products or services to meet those needs.  
There has been exponential growth in the use of MMAs by both clinicians (Lewis & Wyatt, 2014) and 
patients (Taylor, 2015). Now, data‐driven MMAs are rapidly iterating (Terry, 2017). Healthcare providers 
are increasingly utilizing data‐mining to gain insights into their patient populations (Hede, 2016), and 
fast‐emerging technologies such as virtual reality offer considerable promise for future mental health 
diagnosis and treatment (Freeman et al., 2017). In the mental health space, one of the largest technology 
deployments is the Veterans Administration's Recovery Engagement and Coordination for Health 
(REACH VET) program (Office of Public Affairs Media Relations, 2016). The program is attempting to 
reduce the 20‐a‐day veteran suicide rate by scanning six million patient records with predictive modeling 
software designed to determine which veterans are at the highest risk of suicide. There is growing 
evidence that AI/Machine Learning platforms fed large clinical databases produce more accurate 
prediction of suicide attempts than traditional methods (Walsh, Ribeiro, & Franklin, 2017).  
Smartphones, their operating systems, and app ecosystems are what technologists label “platforms.” 
Platforms have value in connecting consumers to available apps and the services they perform directly 
(such as diabetes management) or link to (such as a home visit from a physician). Other platforms connect 
persons with other persons for some kind of mutual benefit (Church, 2017). Thus, social media networks 
such as Facebook are platforms. Some of these apps or other platforms may rely on data‐mining.  
More than 250,000 mobile medical apps (MMAs) are available for download. More than half of mobile 
phone users have downloaded a health‐related mobile app (Krebs & Duncan, 2015). Regarding mental 
health applications, a simple search of the “medical” section of the U.S. App Store (Apple, Inc., 2017a) 
using the term “depression” yielded in excess of 100 apps. A broader “mental health” search of the same 
section returned an apparently random collection of apps promising help with anxiety, promoting 
hypnosis, recovery guides, bipolar symptom charting, alcohol consumption trackers, meditation guides, 
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suicide assessment, and so on. Given the sheer number of these apps and the anticipated growth in this 
market, a frame for thinking about what these apps do and how they might be regulated is proposed.  
3 TYPOLOGY 
There are already general typologies for MMAs (Terry, 2015) and it is now possible to identify at least 
four types of MMA or web‐based app that concern mental health.  
3.1 Self‐assessment or self‐help 
Many MMAs focus on depression with algorithms initiated by a complaint of depression or one of its 
synonyms by the user. These apps may be mood charts seeking primarily to identify symptoms and make 
the user aware or they may attempt to leverage cognitive‐behavioral therapy or behavioral activation to 
treat symptoms or problems entered by the app user. Many of the apps are essentially electronic 
“wrappers” built around the Patient Health Questionnaire (PHQ‐9; Kroenke & Sptizer, 2002), which is a 
tool that catalogs symptoms of depression, asks users to rate the frequency of nine symptoms, and then 
asks users to estimate the level of disability caused by these symptoms. Self‐help apps are also emerging. 
For example, one such app asks how you are feeling and suggests “missions” designed to improve your 
mood (Bakker & Rickard, 2017).  
There is evidence that app‐collected results correlate with those from clinical administration of the 
instrument (Torous et al., 2015). Other such assessment tools, such as Ecological Momentary 
Assessment, are also migrating to app platforms (Firth, Torous, & Yung, 2016). In late 2017, the FDA 
approved the “reSET” MMA, a prescription digital therapeutic designed to aid the treatment of substance 
abuse (United States Food and Drug Administration, 2017).  
3.2 Connecting patients with online support groups 
There is growing interest in designing social media support groups or other services designed to connect 
those with mental health problems to terrestrial or virtual sources of peer support (VanHemert, 2017). For 
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example, there are MMAs under development that have users enter contact information for their real‐
world friends and support group. Thereafter, a tap on the screen alerts the support group that the user 
needs help (SocialCode, 2014).  
3.3 Connecting patients with human or virtual therapists 
A similar model underlies MMAs that connect patients to mental health providers with the goal of 
providing video‐based counseling or providing more general medical services. (Doctor On Demand, 
2017). Other services are specific to mental health counseling (AbleTo, 2017). There is some indication 
that future therapy platforms will replace human therapists with AI‐based models using analysis of 
empathic communications and non‐verbal communications. For example, “Woebot is an automated 
conversational agent (chatbot) who helps the user monitor mood and learn about him or herself drawing 
from a therapeutic framework known as Cognitive Behaviour Therapy” (Molteni, 2017; Woebot Labs, 
2017).  
3.4 Predicting mental health issues 
As is the case with MMAs generally, the controversial goals of some mental health app developers are 
patient‐specific diagnosis and/or avoidance of dangerous behaviors. Current predictive apps tend to use 
physiological signs such as increased pulse or respiration as “tells” specifically indicating times of 
increased mental health symptoms. For example, Spire is a wearable electronic device that attempts to 
detect tension from breathing patterns (Spire, 2017). Future apps include ones that monitor facial 
expression and suggest a food type designed, for example, to reduce anxiety (Knapton, 2016). However, 
AI (specifically data‐mining feeding predictive algorithms) will be increasingly important in predicting 
mental health issues before they occur or, at least, before they are diagnosed (Franklin et al., 2017).  
Facebook, although not an MMA, does have platform characteristics. It combines several MMA‐like 
features, integrating suicide prevention tools to in its “apps” such as Facebook Live and chat support 
through Messenger with crisis support organizations such as the National Suicide Prevention Lifeline. Its 
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approach to indications of possible suicide initially relied on “friend” reporting. However, increasingly it 
is turning to AI and pattern recognition to flag posts for review by the company's community operations 
team (Constine, 2017; Facebook, 2017).  
4 APP‐BASED MENTAL HEALTH INTERACTIONS: CONCERNS AND REGULATORY 
MODELS 
There are well‐established concerns surrounding MMAs, such as their quality, safety, and data security 
(Terry, 2015). Just as these technologies broadly tend to be either provider‐facing or consumer/patient‐
facing, so that distinction is also helpful in determining the type or level of regulation. In general terms, 
the Food and Drug Administration (FDA) has shown more interest in regulating provider‐facing MMAs 
as medical “devices” than in pursuing those that are consumer/patient‐facing, which are often considered 
to be self‐help, education, or recreation. As discussed in the following, this tendency has been confirmed 
by recent legislation and policy statements from the agency.  
Provider‐facing apps also are somewhat more likely to be covered by the federal Health Insurance 
Portability and Accountability Act (HIPAA) privacy and security rules (HIPAA Administrative 
Simplification Regulation Text, 2013) because they are prone to use or prescription by healthcare 
professionals (“covered entities”). However, app developers, data storage or processing companies, and 
consumers will seldom fall under that regulatory language. As a result, most MMAs exist in a relatively 
unregulated “HIPAA‐free zone.”  
In contrast, the jurisdiction of the Federal Trade Commission (FTC) is not limited by sector and applies to 
data custodians both inside and outside the HIPAA “zone” (In the Matter of LabMD, Inc., a corporation, 
2016). However, in general the FTC's consumer protection powers are limited to cases involving 
deceptive or misleading conduct or claims by developers or data companies and not applicable to the 
intrinsic quality or data protection properties of MMAs. Overall, because of gaps in regulatory models 
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and different priorities followed by regulators, the quality, safety, and data protection concerns regarding 
MMAs are amplified by regulatory indeterminacy (Terry, 2016).  
In addition to concerns about specific apps, mobile hardware and software platforms are still relatively 
immature. For example, at least one of the mobile platforms is still plagued by multiple security flaws 
such as malware (Greenberg, 2017) and remote code execution (Nichols, 2017). Furthermore, some 
mental health apps are attempting to leverage features that are still new enough that they should be 
viewed as almost experimental. This is particularly the case with voice interactions: “When asked simple 
questions about mental health, interpersonal violence, and physical health, [conversational agents] 
responded inconsistently and incompletely” (Miner et al., 2016).  
5 QUALITY AND EFFICACY 
It is relatively simple for even a novice user of, say, GPS or social media mobile apps to determine 
whether they are efficacious (i.e., they do what they claim) and possess an interface or feature‐set of 
appropriate quality. It is far harder to judge the efficacy and quality of MMAs. Indeed, the evidence base 
for mental health MMAs is extremely low. This is true even for apps that are recommended or curated by 
responsible third parties. For example, only 15% of U.K. National Health Service (NHS)‐accredited app‐
based psychological interventions, were backed by effectiveness data (Leigh, 2016). It would be expected 
that the applicable metric and process for judging MMA quality is the randomized and controlled human 
clinical trial (RCT). However, it has been suggested that participatory research frameworks would be 
better suited to MMA development and would increase preliminary appraisal (Nicholas, Boydell, & 
Christensen, 2016).  
Regarding MMA regulation, the FDA tends to focus on safety issues. Therefore, the question of whether 
apps do what they claim to do is an area that has essentially been ceded to the FTC. The latter agency has 
successfully argued in the courts that an RCT evidence base is required to adequately substantiate health 
claims (POM Wonderful, LLC v. F.T.C., 2015). The FTC has consistently applied this standard in MMA 
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cases. For example, in the case of an app that used a camera phone to photograph a mole and then 
determined the mole's melanoma risk, the developers settled the agency's claims of deceptive marketing 
(Federal Trade Commission, 2015a). Similar results were reached in cases involving developer claims 
that their apps could improve users' vision (Federal Trade Commission, 2015b) or train specific areas of 
the brain, thereby protecting against dementia and Alzheimer's disease (FTC v Lumos Labs, Inc., 2016). 
Mimicking the FTC's federal role, state consumer protection laws and regulators are assuming greater 
importance. For example, in 2017 the New York Attorney General settled claims with three MMA 
developers over misleading claims regarding efficacy and irresponsible privacy practices (New York 
Attorney General, 2017).  
6 SAFETY 
Broadly stated, the legal system takes two approaches to the safety of medical hardware and software: 
pre‐marketing regulation by the FDA; and post‐marketing state tort (liability) law. As to the former, the 
Federal Food, Drug, and Cosmetic Act views most medical software and hardware as “devices,” and so 
subjects them to some form of pre‐marketing scrutiny (21 U.S.C. ch. 9 § 301). Beginning in 2013, the 
FDA has treated MMAs on the basis of sub‐regulatory “Guidance” (Terry, 2015). Essentially, the FDA 
took the position that some MMAs involve such low risk (e.g., coaching, prompting, or communication 
apps) that the agency could exercise its regulatory discretion. This approach, particularly as it applied to 
fitness and other health apps, was confirmed by Congress in the 21st Century Cures Act (Pub.L. 114–255, 
2016). Subsequently, the FDA Commissioner has outlined a less onerous regulatory model for all MMAs, 
abandoning pre‐marketing approval in favor of pre‐certification of some app developers or post‐
marketing surveillance (Cortez, Terry, & Cohen, 2017).  
As to the latter, tort liability is a matter of state law and so is not uniform. However, in general terms, 
strict product liability could apply to the developers and manufacturers of defective hardware and 
software. Such liability could extend to healthcare providers who sponsor or commission MMAs. 
Potentially, healthcare providers who recommend or supply apps to patients could face negligence‐based 
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medical malpractice liability (Terry & Wiley, 2016). Prudent providers should refrain from 
recommending MMAs they are unfamiliar with and favor those that are FDA‐approved, that are curated 
by well‐informed institutions, or that have been subject to favorable peer‐reviewed research.  
7 DATA PROTECTION 
Mobile medical apps have attracted considerable critical attention from privacy advocates. Frequently 
they lack adequate privacy policies and exhibit critical security vulnerabilities, such as failing to employ 
encryption. Most importantly in the U.S., the HIPAA privacy and security rules only apply to “covered 
entities” (essentially legacy healthcare providers) and their business associates (U.S. Department of 
Health and Human Services, 2013). However, as discussed earlier, MMAs tend to be developed outside 
of traditional healthcare spaces with the result that they exist in a lightly regulated, “HIPAA‐free zone” 
(Terry, 2015).  
Even well‐meaning app developers can discover that their MMAs have serious unintended consequences. 
For example, in 2014, the Samaritans, the well‐known U.K.‐based suicide prevention organization, 
launched a predictive app called “Radar” that scanned a user's Twitter feed looking for keywords 
suggesting depression or suicidal ideation (Orme, 2014). However, some users complained that the app 
might expose vulnerable targets to bullying or shaming. The Samaritans ended up closing the app and 
deleting all of the data associated with it (Orme, 2014).  
Mobile medical apps populating the “HIPAA‐free zone” are not completely unregulated. For example, the 
FTC possesses general powers to regulate “unfair or deceptive acts or practices” (15 U.S. Code § 45, 
2017). While the agency has exercised those powers against corporate entities with multiple security 
lapses (Federal Trade Commission, 2015c), most of its data protection cases involve entities failing to live 
up to their own privacy policies (Federal Trade Commission, 2017). The agency also has published data 
protection guidance for app developers (Federal Trade Commission, 2013) and, in cooperation with the 
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FDA and the Department of Health and Human Services, created an interactive guidance for MMA 
developers (Federal Trade Commission, 2016).  
Arguably of greater practical importance in ensuring that data collected by MMAs is protected is “private 
ordering,” whereby app developers are bound by contractual rules. For example, Apple's App Store rules 
prohibit the use of “data gathered in the health, fitness, and medical research context … for advertising or 
other use‐based data mining purposes other than improving health management.” Additional protections 
apply to apps that use HealthKit to support clinical research (Apple, Inc., 2017b). In contrast, doubts have 
been expressed about how effectively Android apps in the Google Play store are screened for malware or 
other security flaws (Castillo, 2017).  
Increasingly, healthcare providers may find themselves drawn into similar roles as the app stores. One 
survey found that more than a third of physicians had recommended a health app to a patient (Comstock, 
2014). The prudent provider should check to see if apps they are asked to recommend are the subject of 
“best practices” publications or have been approved by well‐informed intermediaries. For example, some 
public healthcare systems such as the NHS in the U.K. (Meek, 2015; National Health Service, 2017) and 
VicHealth in Australia (VicHealth, 2017) now curate apps in recommended “libraries.” Overall, with 
regard to data protection, the takeaway for the prudent provider is that in many cases satisfactory data 
protection (e.g., that provided by the HIPAA rules) simply does not apply to many MMAs, suggesting 
that considerable caution is required before making recommendations to patients.  
8 CONCLUSIONS 
Mobile medical apps, including mental health apps, remain in their infancy. Despite this, consumers are 
downloading them in their millions and increasingly trusting them (Elias, 2015). The technology 
platforms they rely on (e.g., phones and wearables) are iterating at an astounding rate of innovation 
(Papillon, 2017). New technologies that will be added to those platforms, such as AI (Reichert, 2017) and 
augmented reality (Elgan, 2017), will be transformative. The next generation of diagnostic and condition‐
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monitoring mental health apps may well (and controversially so) rival trained professionals and challenge 
the primacy and our understanding of the physician–patient relationship. For example, the DARPA‐
funded SimSensei project features virtual agents that display high levels of artificial emotional 
intelligence and engage convincingly in back‐and‐forth interactions with people (Cremin, 2016).  
However, reviews of the risk‐assessment literature suggest that regulatory agencies have been less than 
helpful in developing workable risk frameworks to assess MMAs (Farr, 2014; Lewis & Wyatt, 2014). In 
part, this is a substantive problem. For example, the privacy and security rules that regulate traditional 
provider–patient interactions are inapplicable to most app–patient interactions. Similarly, the FTC has 
relatively limited jurisdiction (and resources) leading to enforcement actions against only the most 
flagrant offenders who mislead consumers. There are also political considerations. Notwithstanding the 
passage of the 21st Century Cures Act, the FDA still has extensive regulatory authority that can be levied 
against many MMAs and wearables. However, the agency seems to be taking a different path, attempting 
to make regulation more palatable to high‐tech companies. The deficiencies of these regulatory 
frameworks must not be allowed to mask the effectiveness, safety, and data protection issues that are 
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